155431-40-6 Usage
Uses
Used in Pharmaceutical Industry:
4-(2,4-Difluorophenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one is used as an antiepileptic agent for the treatment of Lennox-Gastaut syndrome, a severe form of epilepsy. It is utilized for its ability to modulate sodium channel activity in the brain, thereby stabilizing neuronal electrical activity and reducing the frequency of seizures.
The side effects of rufinamide may include dizziness, drowsiness, and nausea, and there is a potential for interaction with other medications. Therefore, its use should be carefully monitored by a healthcare professional to ensure safe and effective treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 155431-40-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,4,3 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 155431-40:
(8*1)+(7*5)+(6*5)+(5*4)+(4*3)+(3*1)+(2*4)+(1*0)=116
116 % 10 = 6
So 155431-40-6 is a valid CAS Registry Number.
155431-40-6Relevant articles and documents
Azole compounds, their production and use
-
, (2008/06/13)
An azole compound represented by the formula (I): STR1 wherein Ar is a substituted phenyl group; R1 and R2 independently are a hydrogen atom or a lower alkyl group, or R1 and R2 may combine together to form a lower alkylene group; R3 is a group bonded through a carbon atom; R4 is a hydrogen atom or an acyl group; X is a nitrogen atom or a methine group; and n Y and Z independently are a nitrogen atom or a methine group which may optionally be substituted with a lower alkyl group, or a salt thereof, which is useful for prevention and therapy of fungal infections of mammals as antifungal agent.
